Laparoscopic treatment feasible for early-stage cervical cancer
MedWire News: Laparoscopically assisted radical hysterectomy (LARH) for early-stage cervical cancer offers favorable peri-operative morbidity and long-term survival rates, study findings show.
"With the advantages of minimal invasiveness, laparoscopic radical hysterectomy by experienced surgeons should be offered to patients and will become mainstream in the future," say Chih-Feng Yen (Chang Gung Memorial Hospital at Linkou, Tao-Yuan, Taiwan) and colleagues.
The researchers investigated whether LARH with pelvic lymphadenectomy (PL) is a viable alternative to radical hysterectomy with bilateral PL - the traditional surgical management of early-stage cervical cancer.
After a median follow-up duration of 92.1 months, the cumulative overall survival and disease-free survival rates were 93 and 91 percent, respectively, among 139 early-stage cervical cancer patients treated with LARH.
The mean operation time was 231 minutes, and intra-operative complications occurred in just nine patients. These included one vascular injury, six cystotomies, one ureteral injury, and one colon injury, almost all of which were repaired or managed laparoscopically.
Yen and team note that their data are better than those previously published for the traditional laparotomic approach, "which offered an 80-85 percent 5-year overall survival rate for early cervical cancer."
MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010
By Sarah Guy